Filter
2044
Filtered Results: 2044
Text search:
pharmaceutical
management
Featured
Recommendations
197
New Publications
571
Language
Document type
No document type
1053
Studies & Reports
373
Guidelines
345
Manuals
94
Strategic & Response Plan
92
Fact sheets
32
Training Material
24
Situation Updates
12
Resource Platforms
11
Infographics
4
Brochures
3
Online Courses
1
Countries / Regions
Kenya
87
Ethiopia
81
India
81
Global
75
South Africa
54
Nigeria
46
Western and Central Europe
46
Sierra Leone
40
Liberia
40
Uganda
38
Ghana
32
Nepal
30
Rwanda
30
Tanzania
29
Namibia
29
Zambia
28
Malawi
26
Africa
25
Bangladesh
25
Ukraine
22
Latin America and the Carribbean
22
Philippines
20
Indonesia
18
Syria
17
Eastern Europe
17
Lesotho
16
Zimbabwe
15
Cambodia
15
South–East Asia Region
13
Myanmar / Burma
13
Eswatini/ Swaziland
13
Congo, Democratic Republic of
12
Botswana
11
West and Central Africa
10
Germany
9
Eastern Europe and Central Asia
9
Cameroon
8
Asia
8
Russia
8
South Sudan
8
Senegal
7
Guinea
7
East and Southern Africa
7
Brazil
7
Thailand
6
Burkina Faso
6
Haiti
6
Western Pacific Region
5
Benin
4
China
4
Albania
4
Laos
4
Mozambique
4
Middle East and North Africa
4
Vietnam
4
Papua New Guinea
4
Pakistan
4
North Macedonia
3
Chile
3
Fiji
3
Afghanistan
3
USA
3
Jordan
3
United Kingdom
3
Egypt
3
Sudan
3
Mali
3
Tajikistan
2
Serbia
2
Kyrgyzstan
2
Lithuania
2
North America
2
Jamaica
2
Lebanon
2
Moldova
2
Yemen
2
Georgia
2
Central African Republic
2
Iraq
2
Timor Leste/ East Timor
1
Australia
1
Kazakhstan
1
Iran
1
Niger
1
Uzbekistan
1
Peru
1
Bulgaria
1
Armenia
1
Venezuela
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Portugal
1
Spain
1
Southern Africa
1
Bolivia
1
Argentina
1
Sri Lanka
1
Romania
1
Palestine
1
Angola
1
Chad
1
Libya
1
Bhutan
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
858
Clinical Guidelines
137
Public Health
107
Key Resources
103
Women & Child Health
50
Pharmacy & Technologies
32
Capacity Building
14
Annual Report MEDBOX
2
Toolboxes
Pharmacy
202
AMR
192
COVID-19
149
Mental Health
105
HIV
101
TB
101
NTDs
65
Rapid Response
61
NCDs
47
Planetary Health
46
Caregiver
42
Ebola & Marburg
36
Conflict
35
Global Health Education
34
Health Financing Toolbox
26
Specific Hazards
14
Refugee
11
Natural Hazards
11
Disability
11
Polio
11
Social Ethics
3
Cholera
2
South Sudan
1
Zika
1
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The Disaster Recovery Framework (DRF) Guide for the Health Sector provides guidance on how to implement a comprehensive, integrated, and structured approach to disaster recovery. Its overarching goal is to minimize the impact of the disaster on communities and help countries to recover quickly and e...
The overall goal of the programme, to reduce the malaria morbidity and mortality by 75% (using 2012 as baseline) by the year 2020, continued to be pursued in 2014. The following areas were identified as some of the priorities for the year: Malaria Case Management under which we have Malaria in Pregn...
This National Action Plan addresses actions needed to be taken in order to combat antimicrobial resistance (AMR) in the country. It is obligatory to raise awareness of antimicrobial resistance and promote behavioral change through public communication
programmes that targets human, animal and plant...
As part of our commitment to the fight against NCDs, Nigeria was signatory to the political declaration at the UN General Assembly High Level Meeting on NCDs in September 2011. Thus, the purpose of this document is to develop and ensure the implementation of policies and p...
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
This report started with a simple question—“How can we tell how much funding is devoted to global health programs?”—and ended (more than two years later) with an answer that is far from simple. As those who have tried know well, tracking health-related funding is challenging in any setting, ...
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collective failure to take the coordinated actions required to reduce such risks. These risks include the expec...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
COVID-19 disproportionately affects the poor and vulnerable. Community health workers are poised to play a pivotal role in fighting the pandemic, especially in countries with less resilient health systems. Drawing from practitioner expertise across four WHO regions, this article outlines the targete...
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is attributed to the se-lective pressure exerted by antib...
Planned and regulated task shifting and task sharing can have a range of benefits. It can ensure a rational optimization of the available health workforce, address health system shortages of specialized health-care professionals, improve equity in access to health care and increase the acceptability...
The Ministry of Health together with its partners realizes that efficient and effective
delivery of clinical care is highly dependent on the availability of appropriately
upgraded environment, which is in well facilitated space. Such facilities and utilities
should always be properly designed, bu...
Chronic kidney disease (CKD) is an important contributor to mortality from noncommunicable diseases. No decrease has been seen for CKD mortality contrary to many other important non-communicable diseases (e.g., cardiovascular disease). The prevalence of CKD and kidney failure are increasing all over...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
August 2020.
Essential diagnostic products areconsidered an integral part of UHC, they are an indispensable element for delivery ofservices andare also a requirement for qualitycare. Despite this realization, a review of the UHC pilot in September 2019 es...
An Advocate’s Guide: Strategic Indicators for Universal Access to Sexual and Reproductive Health and Rights
recommended
This guide was prepared to enable advocates to use data
when advocating for universal access to SRHR at the national,
regional and global levels. It is a direct outcome of the Strategic
SRHR Indicators workshop held in Kuala Lumpur, Malaysia on
21-22 August for the project “Strengthening the N...
The key areas covered are diagnosis, imaging, pathology, surgery, rehabilitation, palliative care and survivorship. It emphasizes a multi-disciplinary team approach which is paramount for quality cancer care. The specific cancers covered are breast, central nervous system, gastroint...
